Global Pharmatech, Inc. Stock

Stocks

GBLP

US37945N1090

OTC Markets Traded
Market Closed - 03:59:56 06/06/2026 HKT 5-day change 1st Jan Change
0.0801 USD +60.18% Intraday chart for Global Pharmatech, Inc. +0.01% +60.20%
1 week+0.01%
Current month+0.01%

Valuation: Global Pharmatech, Inc.

Market Cap 4.72M 4.26M 3.93M 3.56M 6.73M 443M 6.89M 47.13M 18.79M 237M 17.72M 17.35M 755M P/E 2006
-20.5x
P/E 2007 -4.23x
Enterprise Value 2.04M 1.84M 1.7M 1.54M 2.91M 191M 2.98M 20.37M 8.12M 103M 7.66M 7.5M 326M EV / Sales 2006
11.5x
EV / Sales 2007 4.95x
Free-Float
-
Yield 2006 *
-
Yield 2007 -
1 day+60.18%
1 week+0.01%
Current month+0.01%
1 month+0.01%
3 months+0.01%
6 months+60.20%
Current year+60.20%
Current year 0.05
Extreme 0.05
0.08
1 year 0.05
Extreme 0.05
0.08
3 years 0.05
Extreme 0.05
0.35
5 years 0.05
Extreme 0.05
0.6
10 years 0.01
Extreme 0.008
0.9
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -

Financials

2006 2007
Net sales 2.38M 2.14M 1.98M 1.79M 3.38M 223M 3.47M 23.71M 9.45M 119M 8.92M 8.73M 380M 2.82M 2.54M 2.35M 2.12M 4.01M 264M 4.11M 28.13M 11.21M 142M 10.58M 10.36M 451M
Net income -1.23M -1.11M -1.03M -929K -1.76M -116M -1.8M -12.32M -4.91M -62M -4.63M -4.53M -197M -3.3M -2.97M -2.75M -2.48M -4.7M -309M -4.81M -32.92M -13.12M -166M -12.38M -12.12M -527M
Net Debt -2.68 -2.41 -2.23 -2.02 -3.81 -251.22 -3.91 -26.73 -10.65 -134.54 -10.05 -9.84 -428.16 -2.68 -2.42 -2.23 -2.02 -3.82 -251.47 -3.91 -26.76 -10.66 -134.68 -10.06 -9.85 -428.59
Logo Global Pharmatech, Inc.
Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GBLP Stock